HD10 for Early Stages

Status Completed

Clinical Trial Summary

This study is designed to find the optimum radiation dose and number of cycles for an ABVD chemotherapy combined with an involved field irradiation. It is to be tested whether the reduction from 4 to 2 cycles of ABVD and/or the reduction of the radiation dose from 30 to 20 Gy is feasible without a loss of efficacy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00265018
Study type	Interventional
Source	University of Cologne
Contact
Status	Completed
Phase	Phase 3
Start date	May 1998

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00264953` - HD11 for Intermediate Stages	Phase 3
Completed	`NCT00284271` - Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma	Phase 2
Completed	`NCT00265031` - HD12 for Advanced Stages	Phase 3